Ozempic Goes From Threat to Opportunity for Packaged-Food Makers
Companies see single-portion meals, small snacks, and sippable soups appealing to GLP-1 users.
Conagra Marie Callender’s and Healthy Choice brands appeal to GLP-1 users, according to the company.
Photographer: David Paul Morris/BloombergThis article is for subscribers only.
Big Food is warming to Ozempic.
Less than a year ago, the head of Novo Nordisk A/S was fielding calls from “scared” food industry executives about his company’s blockbuster drug that suppressed cravings, and survey data suggested sales could be hurt by lower consumption. Now with a better view of how the medication is affecting behavior, packaged-food companies are trying to profit off of the Ozempic craze.